These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8207207

  • 1. Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases.
    Komschlies KL, Gregorio TA, Gruys ME, Back TC, Faltynek CR, Wiltrout RH.
    J Immunol; 1994 Jun 15; 152(12):5776-84. PubMed ID: 8207207
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG, Younes E, Visscher D, Hamzavi F, Kim S, Lam JS, Montecillo EJ, Ali E, Pontes JE, Puri RK, Haas GP.
    Clin Cancer Res; 1997 Oct 15; 3(10):1799-806. PubMed ID: 9815566
    [Abstract] [Full Text] [Related]

  • 3. Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy.
    Morrissey PJ, Conlon P, Charrier K, Braddy S, Alpert A, Williams D, Namen AE, Mochizuki D.
    J Immunol; 1991 Jul 15; 147(2):561-8. PubMed ID: 1712810
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-2 blocks the antitumour activity caused by depletion of CD25 cells in a murine renal adenocarcinoma model.
    Takeuchi T, Konno-Takahashi N, Kasuya Y, Ogushi T, Nishimatsu H, Kitamura T.
    BJU Int; 2004 Jul 15; 94(1):171-6. PubMed ID: 15217455
    [Abstract] [Full Text] [Related]

  • 5. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
    Chapoval AI, Fuller JA, Kremlev SG, Kamdar SJ, Evans R.
    J Immunol; 1998 Dec 15; 161(12):6977-84. PubMed ID: 9862733
    [Abstract] [Full Text] [Related]

  • 6. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
    Fukuhara H, Matsumoto A, Kitamura T, Takeuchi T.
    BJU Int; 2006 Jun 15; 97(6):1314-21. PubMed ID: 16686731
    [Abstract] [Full Text] [Related]

  • 7. Local tumor irradiation augments the response to IL-2 therapy in a murine renal adenocarcinoma.
    Younes E, Haas GP, Dezso B, Ali E, Maughan RL, Kukuruga MA, Montecillo E, Pontes JE, Hillman GG.
    Cell Immunol; 1995 Oct 15; 165(2):243-51. PubMed ID: 7553889
    [Abstract] [Full Text] [Related]

  • 8. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.
    Robertson MJ, Cameron C, Atkins MB, Gordon MS, Lotze MT, Sherman ML, Ritz J.
    Clin Cancer Res; 1999 Jan 15; 5(1):9-16. PubMed ID: 9918197
    [Abstract] [Full Text] [Related]

  • 9. Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of the myeloid lineage.
    Faltynek CR, Wang S, Miller D, Young E, Tiberio L, Kross K, Kelley M, Kloszewski E.
    J Immunol; 1992 Aug 15; 149(4):1276-82. PubMed ID: 1500718
    [Abstract] [Full Text] [Related]

  • 10. Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.
    Futami H, Jansen R, MacPhee MJ, Keller J, McCormick K, Longo DL, Oppenheim JJ, Ruscetti FW, Wiltrout RH.
    J Immunol; 1990 Dec 15; 145(12):4121-30. PubMed ID: 2258610
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor-1 stimulation of lymphopoiesis.
    Clark R, Strasser J, McCabe S, Robbins K, Jardieu P.
    J Clin Invest; 1993 Aug 15; 92(2):540-8. PubMed ID: 8349796
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M, Hara I, Furukawa J, Oniki S, Nagai H, Miyake H, Fujisawa M.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [Abstract] [Full Text] [Related]

  • 13. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
    von der Weid T, Beebe AM, Roopenian DC, Coffman RL.
    J Immunol; 1996 Nov 15; 157(10):4421-7. PubMed ID: 8906817
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool.
    Melchionda F, Fry TJ, Milliron MJ, McKirdy MA, Tagaya Y, Mackall CL.
    J Clin Invest; 2005 May 15; 115(5):1177-87. PubMed ID: 15841203
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Recombinant murine IL-3 fails to stimulate T or B lymphopoiesis in vivo, but enhances immune responses to T cell-dependent antigens.
    Kimoto M, Kindler V, Higaki M, Ody C, Izui S, Vassalli P.
    J Immunol; 1988 Mar 15; 140(6):1889-94. PubMed ID: 3257991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.